Literature DB >> 16274269

Surgical management of high-grade gliomas.

Joseph C Hsieh1, Maciej S Lesniak.   

Abstract

High-grade gliomas, in particular anaplastic astrocytoma and glioblastoma multiforme, represent two of the most devastating forms of brain cancer. In spite of the poor prognosis, new treatments and emerging therapies are making an impact on this disease. This review discusses the role of the surgical management of high-grade gliomas and provides an overview of the currently available therapies which depend on surgical intervention. At the same time, cutting-edge clinical trials for patients with malignant brain tumors are reviewed to provide further insights into potential future therapies.

Entities:  

Mesh：

Year:  2005        PMID： 16274269     DOI： 10.1586/14737175.5.6.S33

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN： 1473-7175            Impact factor:   4.618


  5 in total

Review 1.  Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma.

Authors:  Azizul Haque; Naren L Banik; Swapan K Ray
Journal:  Neurochem Res       Date:  2007-08-04       Impact factor: 3.996

2.  High-resolution contrast-enhanced, susceptibility-weighted MR imaging at 3T in patients with brain tumors: correlation with positron-emission tomography and histopathologic findings.

Authors:  K Pinker; I M Noebauer-Huhmann; I Stavrou; R Hoeftberger; P Szomolanyi; G Karanikas; M Weber; A Stadlbauer; E Knosp; K Friedrich; S Trattnig
Journal:  AJNR Am J Neuroradiol       Date:  2007-08       Impact factor: 3.825

3.  High incidence of MGMT and RARbeta promoter methylation in primary glioblastomas: association with histopathological characteristics, inflammatory mediators and clinical outcome.

Authors:  Christina Piperi; Marios S Themistocleous; George A Papavassiliou; Elena Farmaki; Georgia Levidou; Penelope Korkolopoulou; Christos Adamopoulos; Athanasios G Papavassiliou
Journal:  Mol Med       Date:  2009-10-12       Impact factor: 6.354

Review 4.  Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments.

Authors:  Mahmoud S Alghamri; Brandon L McClellan; Carson S Hartlage; Santiago Haase; Syed Mohd Faisal; Rohit Thalla; Ali Dabaja; Kaushik Banerjee; Stephen V Carney; Anzar A Mujeeb; Michael R Olin; James J Moon; Anna Schwendeman; Pedro R Lowenstein; Maria G Castro
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.988

Review 5.  Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment.

Authors:  Andrea Franson; Brandon L McClellan; Maria Luisa Varela; Andrea Comba; Mohammad Faisal Syed; Kaushik Banerjee; Ziwen Zhu; Nazareno Gonzalez; Marianela Candolfi; Pedro Lowenstein; Maria Graciela Castro
Journal:  Front Med (Lausanne)       Date:  2022-09-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.